Shin Jai Moo, Sachs George
Department of Physiology and Medicine, University of California at Los Angeles, and VA Greater Los Angeles Healthcare System, Los Angeles, California, USA.
Gastroenterology. 2002 Nov;123(5):1588-97. doi: 10.1053/gast.2002.36593.
BACKGROUND & AIMS: Proton pump inhibitors (PPIs) are covalent inhibitors of the gastric H+,K+-adenosine triphosphatase (ATPase) forming disulfide bonds. Recovery of acid secretion after PPI inhibition may be due to de novo synthesis of pump protein and/or disulfide reduction and reactivation of inhibited pump. The half-time of recovery of acid secretion in rats following omeprazole treatment is approximately 15 hours, whereas pump protein half-life is 54 hours. In humans, the half-life of the inhibitory effect on acid secretion is approximately 28 hours for omeprazole and approximately 46 hours for pantoprazole. Whereas all PPIs bind to cysteine 813, pantoprazole additionally binds to cysteine 822, deeper in the membrane domain of TM6. Their different durations of action may reflect different rates of pump reactivation due to differing accessibility of the disulfides to glutathione.
Rats were stimulated and treated with 30 mg/kg of each PPI. Gastric ATPase was prepared and reversal of inhibition of the H+,K+-ATPase was measured as the time-dependent restoration of activity by incubation with dithiothreitol or glutathione.
One hundred percent reactivation of ATPase following inhibition in vivo by omeprazole or its enantiomers was seen with dithiothreitol and 89% with glutathione. Similar data were found for lansoprazole or rabeprazole. No reactivation by either reducing agent was seen following inhibition by pantoprazole.
Recovery of acid secretion following inhibition by all PPIs, other than pantoprazole, may depend on both protein turnover and reversal of the inhibitory disulfide bond. In contrast, recovery of acid secretion after pantoprazole may depend entirely on new protein synthesis.
质子泵抑制剂(PPIs)是胃H⁺,K⁺ - 腺苷三磷酸酶(ATP酶)的共价抑制剂,可形成二硫键。PPI抑制后胃酸分泌的恢复可能归因于泵蛋白的重新合成和/或二硫键的还原以及被抑制泵的重新激活。奥美拉唑治疗后大鼠胃酸分泌恢复的半衰期约为15小时,而泵蛋白的半衰期为54小时。在人类中,奥美拉唑对胃酸分泌抑制作用的半衰期约为28小时,泮托拉唑约为46小时。虽然所有PPIs都与半胱氨酸813结合,但泮托拉唑还与跨膜结构域TM6中更深层的半胱氨酸822结合。它们不同的作用持续时间可能反映了由于二硫键对谷胱甘肽的可及性不同而导致的泵重新激活速率不同。
用30mg/kg的每种PPI刺激并处理大鼠。制备胃ATP酶,并通过与二硫苏糖醇或谷胱甘肽孵育来测量H⁺,K⁺ - ATP酶抑制的逆转,作为活性随时间的恢复情况。
在体内被奥美拉唑或其对映体抑制后,ATP酶用二硫苏糖醇处理可实现100%重新激活,用谷胱甘肽处理则为89%。兰索拉唑或雷贝拉唑也得到了类似的数据。泮托拉唑抑制后,两种还原剂均未观察到重新激活。
除泮托拉唑外,所有PPI抑制后胃酸分泌的恢复可能取决于蛋白质更新和抑制性二硫键的逆转。相比之下,泮托拉唑抑制后胃酸分泌的恢复可能完全取决于新蛋白质的合成。